|
|
||||||||
1 From the Department of Ophthalmology, University of Washington School of Medicine, Seattle; the 2 Department of Ophthalmology, Korea University, Seoul; and the 3 Department of Ophthalmology, Research Institute of Medical Science, College of Medicine, Pusan National University, Korea.
| Abstract |
|---|
|
|
|---|
and tumor necrosis
factor (TNF)-
on cytokine, chemokine, and receptor expression in
corneal stromal cells; the effect of corneal scrape injury on monocyte
chemotactic and activating factor (MCAF) expression and
monocyte-macrophage influx into the stroma; and the effect of MCAF and
granulocyte colony-stimulating factor (G-CSF) microinjection on
inflammatory cell infiltration into the stroma.
METHODS. Gene array technology was used to evaluate changes in cytokine,
chemokine, and receptor gene expression in stromal fibroblasts in
response to IL-1
and TNF
. Expression of MCAF mRNA and protein was
monitored with an RNase protection assay and Western blot analysis,
respectively. Keratocyte MCAF protein expression in the rabbit cornea
was detected with immunocytochemistry. After epithelial scrape injury,
monocytes-macrophages were detected in rabbit corneas, by
immunocytochemistry for monocytemacrophage antigen. Inflammatory cell
infiltration after MCAF and G-CSF microinjection into the stroma of
mouse corneas was monitored with hematoxylin and eosin staining.
RESULTS. IL-1
or TNF
upregulated the expression of several proinflammatory
chemokines in stromal fibroblasts in culture. These included G-CSF,
MCAF, neutrophil-activating peptide (ENA-78), and monocyte-derived
neutrophil chemotactic factor (MDNCF). MCAF mRNA upregulation was
confirmed by RNase protection assay, and MCAF protein was detected by
Western blot analysis. MCAF protein was detected in keratocytes at 4
hours and 24 hours after epithelial injury, but not in keratocytes in
the unwounded cornea. Corneal epithelial injury triggered the influx of
monocytes-macrophages into the corneal stroma in the rabbit.
Microinjection of MCAF and G-CSF into mouse cornea resulted in the
influx of monocytes-macrophages and granulocytes, respectively, into
the stroma.
CONCLUSIONS. Proinflammatory chemokine induction in keratocytes is mediated by
IL-1
and TNF
. The proinflammatory chemokines produced by the
keratocytes probably trigger the influx of inflammatory cells into the
stroma after epithelial injury associated with corneal surgery, contact
lenses, or trauma.
| Introduction |
|---|
|
|
|---|
Although there are a number of cytokine receptor systems that may
participate in responses associated with corneal injury, many
investigators have suggested that the interleukin (IL)-1 system is
especially important. IL-1 is produced constitutively in the
epithelium, but not in keratocytes, in the unwounded cornea and is
released by injury or death of epithelial cells.4
5
IL-1
has been shown to modulate keratocyte apoptosis,6
7
keratocyte-myofibroblast hepatocyte growth factor and keratinocyte
growth factor production associated with control of epithelial
healing,5
8
and keratocyte-myofibroblast collagenase and
metalloproteinase production involved in stromal
remodeling.9
10
IL-1 may also modulate the functions of
other cytokines, such as the effect of platelet-derived growth factor
(PDGF) on stromal fibroblast chemotaxis.11
Some of these
functions of IL-1 appear to be shared by the tumor necrosis factor
(TNF)-
TNF receptor system.12
In this study, gene array technology was used to further explore the
effects of IL-1
and TNF
on the expression of cytokines,
chemokines, and receptors in the cornea. These experiments confirmed
that IL-1
and TNF
upregulate several chemokines in corneal
fibroblasts that are involved in chemotaxis and activation of immune
cells. Corneal epithelial injury or microinjection of these chemokines
attracts inflammatory cells into the corneal stroma.
| Materials and Methods |
|---|
|
|
|---|
(R&D Systems,
Minneapolis, MN), 20 ng/ml human TNF
(R&D Systems), or vehicle.
Cells were used immediately after incubation with cytokines or vehicle
for isolation of RNA for gene array analysis or RNase protection assay.
Human CytokineChemokine Receptor Gene Array
An Atlas human cDNA expression array (Clontech, Palo Alto, CA)
that has 268 known cytokinechemokine receptor genes represented was
used in these experiments. A complete list of the 268 genes included in
this human array can be found at http://www.clontech.com.
Total RNA was isolated using RNA extraction reagent (TRIzol; Gibco BRL,
Rockville, MD) according to the manufacturers instructions. After
DNase treatment, 32P-labeled cDNA probe was
synthesized from total RNA according to the manufacturers protocol.
Each cDNA probe was purified using Chroma-spin columns
(Clontech). Incorporation of label was assessed using scintillation
counting. Equal counts per minute (cpm; 2 x
106) of cDNA probe from the IL- 1
, TNF
, or
control group were hybridized in hybridization solution (Express Hyb;
Clontech) to the cytokinechemokine receptor array membranes overnight
at 68°C with continuous agitation. The arrays were washed in wash
solution 1 (2x SSC, 1% SDS) and wash solution 2 (0.1x SSC, 0.5%
SDS) at 68°C. The array membranes were exposed to x-ray film
(BioMax MS; Eastman Kodak, Rochester, NY) at -70°C.
Autoradiographic results were analyzed and compared by computer (Atlas Image 1.1 software; Clontech). This software automatically averages the two hybridization signals for a particular gene and compares this intensity to the same gene in the control array. Exposure times between 4 and 48 hours were used. Lower exposure times were used for comparison of genes with high expression. Results were consistent when different exposure times were compared, but signal spread necessitated analysis of lower exposures for some genes. Using the quantitation obtained with this software for analysis of differences between experimental and control arrays, only positive or negative intensity differences between the cytokine-treated cellprobed arrays and the vehicle-treated cellprobed arrays that were greater than 12,000 were accepted as significant. This cutoff determined by the computer program is arbitrary, but represents a highly significant difference. Further description of this quantitation can be obtained at the Web site provided by the manufacturer (http://www.clontech.com).
RNase Protection Assay Analysis of MCAF mRNA Production in Human
Stromal Fibroblasts
Total RNA was extracted from HSF using extraction reagent
(TRIzol; Gibco). A cDNA fragment for human MCAF was generated using
polymerase chain reaction (PCR) with primers
(5'-TGCTCATAGCAGCCACCTTC-3' and 5'-TGGGTTTGCTTGTCCAGG-3') designed
according to the published MCAF sequence (GenBank accession
number, X14768). The conditions for PCR were 94°C for 1
minute; 35 cycles of 94°C for 30 seconds, 55°C for 30 seconds, and
72°C for 1 minute; and 72°C for 7 minutes in a programmable thermal
controller (PTC-100; MJ Research, Inc., Watertown, MA). The PCR product
was cloned into the pCR II vector (Invitrogen, San Diego, CA) and
sequenced using standard methods to confirm that the sequence was
correct.
An RNase protection assay (RPA) was performed using the published
method.13
Briefly, the RNA probe was synthesized using the
linearized MCAF cDNA (253 bp) as a template, along with T7 RNA
polymerase (Roche, Indianapolis, IN), [
-32P]-UTP (800 Ci/mmol; NEN, Boston, MA), and unlabeled
nucleotides.13
The RNA probe was purified by ethanol
precipitation to remove unincorporated labeled nucleoside triphosphates
(Promega, Madison, WI). Twenty micrograms of total cellular
RNA13
made from the HSF cells treated with TNF
,
IL-1
, or vehicle control were incubated in hybridization buffer
containing 2 x 106 cpm of labeled RNA probe
at 45°C overnight. The hybridization mixture was digested using 40
µg/ml RNase A and 1000 U/ml RNase T1 (Sigma, St. Louis, MO) at 30°C
for 1 hour. The protected MCAF mRNAs were analyzed on a 6% sequencing
gel. The dried gel was exposed to film (BioMax; Eastman Kodak) for 2
hours.
Western Blot Detection of MCAF Protein Production by Stromal
Fibroblasts
Confluent first-passage HSFs in 60-mm2
culture plates with 1 ml serum-free medium were treated with 20 ng/ml
IL-1
(R&D Systems), 20 ng/ml TNF
(R&D Systems), 250 ng/ml
Fas-activating IgM (Upstate Biotechnology, Lake Placid, NY), or vehicle
for 24 hours or 48 hours. Protein in the conditioned medium was
measured with protein detection reagent (Bio-Rad, Richmond, CA) and
diluted to a concentration of 0.26 mg/ml with PBS. Twenty-five
microliters of diluted conditioned medium was loaded in each lane.
Western blot analysis was performed to detect proteins using a
published method.13
Two micrograms per milliliter
anti-human MCAF (MCP-1) monoclonal antibody (mouse IgG1, no. 23007-111;
R&D Systems) were used for the Western blot analysis. The secondary
antibody (anti-mouse IgG conjugated with alkaline phosphatase; Promega)
and 5-bromo-4-chloro-3-indoyl phosphate 4-toluidine salt/nitroblue
tetrazolium chloride (BCIP/NBT) color development substrate (Promega)
were used to detect the first antibody according to the instructions of
the manufacturer. Prestained protein molecular weight standards
(Amersham Life Sciences, Inc., Arlington Heights, IL) were run
simultaneously on the 15% polyacrylamide gel to determine the size of
the proteins. All other reagents were obtained from Sigma.
Detection of MCAF Protein by Immunocytochemistry
The rabbit corneoscleral rims were removed with 0.12-mm forceps
and sharp Westcott scissors. The tissue was fixed in 4%
paraformaldehyde (no. 19202; Electron Microscope Sciences, Fort
Washington, PA) at room temperature for 6 hours. After fixation, the
corneas were placed in 30% sucrose overnight at 4°C and mounted in
optimal temperature cutting (OCT) compound (Tissue-Tek, Torrance, CA)
the next day. Cryostat sections were cut at 10 µm thickness and
mounted on microscope slides (no. 48311-703; VWR, West Chester, PA).
The rabbit corneal sections were pretreated with blocking solution containing 5% horse serum provided in an immunostaining kit (Vectastain TM Elite Kit, no. PK-6102; Vector Laboratories, Burlingame, CA), 1% BSA, and 1% Triton-100 (no. T9284; Sigma) in phosphate-buffered saline (PBS; 0.05 M phosphate buffer, 0.137 M NaCl [pH 7.45]; Sigma) for 30 minutes at room temperature. The mouse monoclonal IgG1 anti-human MCAF antibody, which had been shown by the manufacturer to bind rabbit MCAF, was diluted to 1 µg/ml in PBS containing 1% Triton X-100. The sections were incubated with primary antibody overnight at 25°C. Negative controls were incubated with isotype-matched nonspecific control antibody or without primary antibody. Immunostaining was performed with the kit (Vectastain TM Elite Kit; Vector), according to the manufacturers instructions. 3,3-Diaminobenzidine (DAB; no. D-5905; Sigma) was used to visualize the label. Glycerol was applied to the sections on the slide, and a coverslip was placed into position.
Immunohistochemistry for MonocytesMacrophages
Corneal epithelial scrape injury was performed with a scalpel
blade in one eye of New Zealand White rabbits, by using previously
reported methods.14
The corneoscleral rims were removed
with 0.12-mm forceps and sharp Westcott scissors. The tissue was fixed
in 4% paraformaldehyde at room temperature for 6 hours. After
fixation, the corneas were placed in 30% sucrose overnight at 4°C
and mounted in OCT compound the next day. Cryostat sections were cut at
10-µm thickness and mounted on microscope slides.
The 24-hour scraped and normal rabbit cornea sections were pretreated with blocking solution containing 5% rabbit serum provided in the staining kit (Vectastain; Vector) and 1% Triton X-100 (no. T9284; Sigma) in PBS for 30 minutes at room temperature. The rat anti-mouse monocyte-macrophagespecific monoclonal antibody (no. RDI-T2008X; R&D Systems Inc.) shown to recognize rabbit antigen was diluted to 1 µg/ml in PBS containing 1% Triton X-100. The sections were incubated with primary antibody overnight at 25°C. Immunolabeling was performed according to the manufacturers method. DAB was used to visualize the labeling, and the sections were coverslipped with glycerol.
Microinjection of MCAF or G-CSF into the Corneal Stroma
Mice (C-56/J6) were used because rabbit chemokines are not
available from commercial suppliers. Mice were anesthetized by
intraperitoneal injection of xylazine 5 mg/kg and ketamine 50 mg/kg.
The eye was anesthetized by topical application of a drop of
proparacaine 1% just before microinjection.
Microinjection was performed using a syringe microinjection system (Hamilton, Reno, NV) with drawn glass capillary needle attached to the blunt needle provided for the system with polyethylene tubing. Mouse MCAF (MCP-1, no. 479-JE-050; R&D Systems, Inc.) or mouse G-CSF (no. 414-CS-025; R& D Systems) were diluted in the carrier solution (1x PBS, 0.5% BSA) at a concentration of 100 ng/µl. The MCAF solution, G-CSF solution, or carrier control solution was drawn into the glass needle. The tip of the sterile needle was passed through the limbus and advanced into the central stroma under direct, magnified observation with an operating microscope. Microinjection of 1 µl was performed, and the needle was withdrawn. After 24 or 48 hours the animal was placed under general anesthesia and killed with 100 mg/kg intraperitoneal pentobarbital. The eyes were removed with fine scissors and forceps, fixed overnight in 37% buffered formaldehyde solution (Sigma), and embedded in paraffin. Eight-micrometer sections were cut with a keratome and placed on 25 x 75 x 1-mm microscope slides (Superfrost Plus; Fisher, Houston, TX). Sections were deparaffinized using standard techniques before hematoxylin and eosin staining. Micrographs were obtained with a fluorescence light microscope (model E600; Nikon, Melville, NY).
| Results |
|---|
|
|
|---|
treated HSFs (Fig. 1
, Table 1
). At least 7 of these genes code for cytokines or chemokines
involved in the chemotaxis or activation of inflammatory cells (Table 1)
. Twenty genes were downregulated in HSFs in response to IL-1
(Fig. 1
, Table 2
). Fifteen of the tested genes were upregulated in HSFs in response to
TNF
(Fig. 1
, Table 3
). Thirteen genes were downregulated in response to TNF
(Fig. 1
,
Table 4
).
|
|
|
|
|
and TNF
. For example, G-CSF, neutrophil-activating peptide, and
erythroid differentiation protein mRNAs were upregulated in HSFs in
response to IL-1
or TNF
.
The gene array experiments with IL-1
and TNF
were performed twice
with highly consistent results in the two experiments.
The upregulation of several genes that code for inflammatory cell
chemotactic proteins in HSFs by IL-1
or TNF
suggests a
cell-interactive mechanism for attracting inflammatory cells to the
cornea in response to IL-1
or TNF
released from the epithelium by
injury. One of these genes that appeared to be markedly upregulated was
MCAF, also called MCP-1. This led us to study the
expression of MCAF more completely both in vitro and in vivo.
Upregulation of MCAF mRNA in HSFs in response to IL-1
or TNF
was
confirmed using the quantitative RNase protection assay (Fig. 2A)
. This experiment was repeated three times, and consistent results were
obtained in each experiment. Thus, either IL-1
or TNF
upregulates
the expression of the MCAF gene in HSFs in vitro.
|
or TNF
exposure. This
experiment was repeated three times, and the results were consistent
between the experiments. The effect of scrape injury on MCAF protein expression in the rabbit cornea was examined with immunocytochemistry (Fig. 3) . No MCAF protein was detected in keratocytes in the unwounded cornea (Fig. 3A) . There was heavy staining at the apical surface of the epithelium, suggesting high levels of MCAF on the corneal surface. At 4 hours (Fig. 3B) and 24 hours (Fig. 3C) after corneal epithelial scrape injury there was marked upregulation of MCAF protein expression in the keratocytes in the posterior stroma. There was little MCAF detected in the anterior stroma, consistent with apoptosis of anterior keratocyte cells that occurs after corneal epithelial scrape injury.6 This experiment was repeated three times with identical results each time.
|
|
|
| Discussion |
|---|
|
|
|---|
appears to be especially important, because it
regulates many processes that are integral to the response to injury.
These include keratocyte apoptosis,6
7
expression of
hepatocyte growth factor and keratinocyte growth factor production by
keratocytes and myofibroblasts,5
8
and keratocyte
collagenase and metalloproteinase production.9
10
11
IL-1
is produced constitutively in the corneal epithelium and is released by
injury or death of the epithelial cells.1
2
3
4
6
IL-1
is
not detectable in keratocytes in the unwounded cornea.4
IL-1
released from injured corneal epithelial cells triggers an
autocrine loop in viable keratocytes resulting in production of IL-1
in the stroma of the acutely wounded cornea.10
The wide
range of effects controlled by IL-1
have led us to consider it a
master regulator of the response to acute corneal injury. TNF
is
probably also released after injury to the epithelium and may
contribute to the response to wounding.12
In this study, we examined the effects of IL-1
and TNF
on the
expression of a number of cytokines, chemokines, and receptors in
cultured human corneal stromal fibroblasts, by using gene array
technology. Several cytokines, chemokines, and receptors were
upregulated in stromal fibroblasts in response to IL-1
(Table 1)
. A
few were downregulated by IL-1
(Table 2)
. Similarly, TNF
modulated the expression of several cytokine, chemokine, and receptor
genes in stromal fibroblasts (Tables 3
4)
. The effects of IL-1
and
TNF
were similar for some of the cytokine and receptor genes
represented on the array. IL-1
or TNF
, however, had specific
effects on other cytokine and receptor genes evaluated by gene array
technology.
A striking aspect of the results from the array experiments was the
number of genes upregulated in stromal fibroblasts by IL-1
and/or
TNF
(of the 268 total represented on the array) that function in the
chemotaxis, proliferation, differentiation, and activation of
inflammatory cells. Thus, G-CSF,16
17
MCAF,18
19
neutrophil-activating peptide
(ENA-78),20
21
monocyte-derived neutrophil chemotactic
factor (MDNCF or IL-8),22
23
and
interleukin-424
25
26
were all upregulated in stromal
fibroblasts by IL-1
. G-CSF and neutrophil-activating peptide
(ENA-78) were upregulated by TNF
. These and other inflammatory
cytokines and chemokines that were upregulated are indicated by bold
lettering in Tables 1
and 3 .
Upregulation of these cytokines in cultured stromal fibroblasts in
response to IL-1
and TNF
is of particular interest, because they
could function as the modulators that trigger the known inflammatory
cell infiltration that occurs in vivo approximately 24 hours after
corneal epithelial scrape injury.27
In the current study,
we detected a large number of cells expressing
monocyte-macrophagespecific antigen in the corneal stroma at 24 hours
after corneal epithelial scrape injury, consistent with this hypothesis
(Fig. 4)
. In addition, another recent study used electron microscopy to
show that large numbers of polymorphonuclear cells infiltrate the
corneal stroma at 24 and 72 hours after epithelial injury (Mohan et
al., unpublished data, 2001).
MCAF18
19
was one of the cytokines that was markedly
upregulated in stromal fibroblasts by IL-1
or TNF
. A similar
result was reported in a previous study for MCAF in
vitro.28
That study and the current one suggest a
cytokine-mediated mechanism leading to the chemotactic attraction of
inflammatory cells, such as monocytes or macrophages, which infiltrate
the stroma approximately 24 hours after corneal epithelial injury.
Consistent with this hypothesis, keratocytes expressed MCAF protein
detected by immunocytochemistry at 4 and 24 hours after corneal
epithelial scrape injury (Fig. 3) . No MCAF was detected in the
keratocytes in the unwounded cornea (Fig. 3)
. Cells expressing
monocyte-macrophagespecific antigen appeared in the cornea after
epithelial scrape injury (Fig. 4)
. Finally, microinjection of MCAF into
the corneal stroma triggered the influx of inflammatory cells that had
morphology consistent with monocytes-macrophages (Fig. 5)
.
Cultured stromal fibroblasts produced low levels of MCAF and other
proinflammatory cytokines and chemokines in the absence of IL-1
or
TNF
(Figs. 1
2A
2B)
. In the case of MCAF, no production was noted
in the unwounded cornea in vivo. Thus, MCAF production in keratocytes
in vivo was detected only after the epithelium was injured. Some
investigators have noted that cultured stromal fibroblasts are more
similar to wound-healing fibroblasts than the keratocytes in the
unwounded cornea in vivo.29
30
Thus, the production of
MCAF and the other cytokines and chemokines (Fig. 1)
in cultured
stromal fibroblasts in the absence of IL-1
or TNF
may be more
representative of the keratocyte-derived cells in the wounded cornea
(i.e., myofibroblasts or wound-healing fibroblasts) than of keratocytes
in vivo.
G-CSF was also upregulated in stromal fibroblasts by IL-1
or TNF
.
Microinjection of G-CSF triggered the influx of cells into the stroma
that had the morphology of granulocytes (Fig. 5)
. Thus, G-CSF may have
an important role in regulating the influx of granulocytes into the
cornea.
Cytokine-mediated induction of proinflammatory chemokine production by keratocytes may have an important role in modulating the influx of inflammatory cells into the cornea. Such communications are probably important in many corneal conditions associated with inflammatory cell infiltration, including infection, contact lensinduced sterile infiltrates, and the inflammatory cell influx associated with refractive surgical procedures, such as LASIK and photorefractive keratectomy.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported in part by Grants EY10056 and EYO1730 from the National Eye Institute and an unrestricted grant from Research to Prevent Blindness.
Submitted for publication February 13, 2001; revised May 9 and July 13, 2001; accepted July 24, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked
"advertisement" in accordance with 18 U.S.C.
1734
solely to indicate this fact.
Corresponding author: Steven E. Wilson, Department of Ophthalmology, University of Washington School of Medicine, Box 356485, Seattle, WA 98195-6485.
| References |
|---|
|
|
|---|
-induced apoptosis in corneal fibroblasts by transcription factor NF-kb Invest Ophthalmol Vis Sci 41,1327-1336This article has been cited by other articles:
![]() |
K. Kimura, S. Teranishi, K. Fukuda, K. Kawamoto, and T. Nishida Delayed Disruption of Barrier Function in Cultured Human Corneal Epithelial Cells Induced by Tumor Necrosis Factor-{alpha} in a Manner Dependent on NF-{kappa}B Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 565 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakao, Y. Hata, M. Miura, K. Noda, Y. N. Kimura, S. Kawahara, T. Kita, T. Hisatomi, T. Nakazawa, Y. Jin, et al. Dexamethasone Inhibits Interleukin-1{beta}-Induced Corneal Neovascularization: Role of Nuclear Factor-{kappa}B-Activated Stromal Cells in Inflammatory Angiogenesis Am. J. Pathol., September 1, 2007; 171(3): 1058 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Chou, S.-W. Chang, and J.-L. Chuang Mitomycin C Upregulates IL-8 and MCP-1 Chemokine Expression via Mitogen-Activated Protein Kinases in Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2009 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ebihara, S. Yamagami, S. Yokoo, S. Amano, and A. Murakami Involvement of C-C Chemokine Ligand 2-CCR2 Interaction in Monocyte-Lineage Cell Recruitment of Normal Human Corneal Stroma J. Immunol., March 1, 2007; 178(5): 3288 - 3292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Chintakuntlawar, R. Astley, and J. Chodosh Adenovirus Type 37 Keratitis in the C57BL/6J Mouse Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 781 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bitko, A. Musiyenko, and S. Barik Viral Infection of the Lungs through the Eye J. Virol., January 15, 2007; 81(2): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ayala, D. J. Warejcka, M. Olague-Marchan, and S. S. Twining Corneal Activation of Prothrombin to Form Thrombin, Independent of Vascular Injury Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 134 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu, Y. Liu, K. Fukuda, Y. Nakamura, N. Kumagai, and T. Nishida Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3796 - 3800. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, A. R. Burns, and C. W. Smith Two Waves of Neutrophil Emigration in Response to Corneal Epithelial Abrasion: Distinct Adhesion Molecule Requirements Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1947 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamagami, N. Ebihara, T. Usui, S. Yokoo, and S. Amano Bone Marrow-Derived Cells in Normal Human Corneal Stroma Arch Ophthalmol, January 1, 2006; 124(1): 62 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saghizadeh, A. A. Kramerov, J. Tajbakhsh, A. M. Aoki, C. Wang, N.-N. Chai, J. Y. Ljubimova, T. Sasaki, G. Sosne, M. R. J. Carlson, et al. Proteinase and Growth Factor Alterations Revealed by Gene Microarray Analysis of Human Diabetic Corneas Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3604 - 3615. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xiao and J. Chodosh JNK Regulates MCP-1 Expression in Adenovirus Type 19-Infected Human Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3777 - 3782. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. McInnis, A. Britain, R. N. Lausch, and J. E. Oakes Synthesis of {alpha}-Chemokines IP-10, I-TAC, and MIG Are Differentially Regulated in Human Corneal Keratocytes Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1668 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Hao, K. Suzuki, Y. Lu, S. Hirano, K. Fukuda, N. Kumagai, K. Kimura, and T. Nishida Inhibition of Gap Junction-Mediated Intercellular Communication by TNF-{alpha} in Cultured Human Corneal Fibroblasts Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1195 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Wilson and M. V. Netto Refractive Surgery and Cornea: The Never-Ending Spiral of Technology Arch Ophthalmol, February 1, 2005; 123(2): 265 - 266. [Full Text] [PDF] |
||||
![]() |
S. A. K. Harvey, S. C. Anderson, and N. SundarRaj Downstream Effects of ROCK Signaling in Cultured Human Corneal Stromal Cells: Microarray Analysis of Gene Expression Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2168 - 2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Lee, D. J. Evans, and S. M. J. Fleiszig Role of Pseudomonas aeruginosa ExsA in Penetration through Corneal Epithelium in a Novel In Vivo Model Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5220 - 5227. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ivarsen, T Laurberg, and T Moller-Pedersen Characterisation of corneal fibrotic wound repair at the LASIK flap margin Br J Ophthalmol, October 1, 2003; 87(10): 1272 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. M. Spandau, A. Toksoy, S. Verhaart, R. Gillitzer, and F. E. Kruse High Expression of Chemokines Gro-{alpha} (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in Inflamed Human Corneas In Vivo Arch Ophthalmol, June 1, 2003; 121(6): 825 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamagami, S. Yamagami, T. Inoki, S. Amano, and K. Miyata The Effects of Proinflammatory Cytokines on Cytokine-Chemokine Gene Expression Profiles in the Human Corneal Endothelium Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |